Desethylamiodaron zur Verwendung in der Krebsbehandlung

Details

Veröffentlichungs-Nr.

EP3173081

Aktenzeichen

EP15197046

Anmeldetag

30. November 2015

Veröffentlichung

25. September 2019

Erteilung

25. September 2019

Rechtsraum

EP

IPC

A61K31/343A61P35/00A61P35/04

Abstract

The invention relates to a compound selected from the group consisting of desethylamiodarone and pharmaceutically acceptable salts, hydrates and solvates thereof, as well as pharmaceutical composition comprising the compound together with a pharmaceutically acceptable excipient, vehicle or carrier, for use in the treatment of a proliferative disorder.

Anmelder

Firma

Pécsi Tudományegyetem

Land

🇭🇺 Ungarn

Fachgebiete